Cost-Effectiveness of Rapid Susceptibility Testing for Second Line Drugs against Tuberculosis.

Dowdy DW, van’t Hoog AH, Shah M, Cobelens FGJ.

Int J Tuberc Lung Dis 2014;18(6):647-54.

Abstract  http://www.ncbi.nlm.nih.gov/pubmed/?term=Cost-Effectiveness+of+Rapid+Susceptibility+Testing+for+Second+Line+Drugs+against+Tuberculosis